News

Jack Armstrong, president and CEO said: “Genaera is privileged and honored to work with this prestigious group of nationally and internationally recognized experts to guide our trodusquemine (MSI-1436)

The data were collected as part of the company's ongoing pivotal trial for SinuNase, an intranasal formulation of the antifungal amphotericin B 0.01% suspension. In order to be

Under the terms of the settlement, the license agreement will remain in full force and effect until March 31, 2008. Furthermore, Pohl-Boskamp has agreed to pay Stellar E200,000,

The trial design is a US multicenter, randomized, double-blind, placebo-controlled study of subcutaneous Tovaxin in subjects with clinically isolated syndrome or relapsing/remitting multiple sclerosis. More than 60% of

Results for the trial, which evaluated TPI-1020, showed a good safety and tolerability profile, in addition to certain anti-inflammatory effects, which could be beneficial in Topigen’s target indication

The marketing authorization applications seek approval for oral alitretinoin in the treatment of severe refractory chronic hand eczema and are based on a clinical program comprising almost 2,000

Equetro (carbamazepine) is a treatment for the acute manic and mixed episodes associated with bipolar-1 disorder – a condition where patients experience extended periods of exaggerated highs in

NGX267, a functionally selective muscarinic (M1) agonist, was found to be safe and well tolerated when given orally to healthy male volunteers once-daily for four consecutive days. In

XP19986 is formulated in a sustained-release tablet, designated as SR3. The trial demonstrated sustained levels of XP19986 over 24 hours and enabled identification of suitable doses for further